BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Applied DNA Sciences, Inc. (APDN) Announces New Director of Europe Operations, Chris Taylor


3/8/2013 8:47:26 AM

STONY BROOK, NY--(Marketwire - March 08, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that Chris Taylor, a recognized leader in forensic marking products, has joined the company as Director, Europe.

APDN welcomed Mr. Taylor, who will help lead the company in comprehensively expanding its offerings in the United Kingdom, the European continent, and in Scandinavia. Taylor formerly was Managing Director of RedWeb Technologies, a provider of advanced forensic tagging and bespoke GPS tracking security solutions.

"I am excited at the chance to extend APDN's market-leading solutions even farther in the European markets," said Mr. Taylor. "With my background in forensic marking, I know that APDN has far and away the most advanced and effective technology, nothing comes close."

Mr. Taylor will drive the commercialization of a fast growing product line. SigNature® DNA, the well-known APDN evidentiary marking product, is now used to protect over 26% of the cash in the United Kingdom as money is moved to and from banks and retailers. The cash in transit technology was also adopted last year by the Scandinavian security firm Nokas AS to be used nationally in Sweden. The company's DNANet product, a tactical forensic marking system, is used by law enforcement in the United Kingdom and Sweden for covert police operations. smartDNA, an anti-intrusion forensic marker, is used to protect over forty jewelry stores in Sweden, and to defend against copper theft in that country.

Mr. Taylor said, "APDN technology is redefining the performance level expected by businesses and law enforcement organizations. We are confident we can now extend into new markets and new territories, including in defense, textiles, and brand protection."

Chris Taylor will report directly to Tony Benson, APDN's Risk & Security Director, based in the United Kingdom. Mr. Benson commented, "I am very pleased to be able to work with Chris. His vast technical knowledge and experience are valued assets for APDN and will help to deliver top-notch solutions for clients and grow our European markets."

Said Dr. James A. Hayward, President and CEO of Applied DNA Sciences, "Chris Taylor brings to the company world class skills in management, in guiding advanced technical products to market, and in all aspects of forensic marking. His blue chip experience with recognized firms in our space will serve the company well as we challenge for leadership in our markets in Europe."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


MEDIA CONTACT:
Mitchell Miller
646-543-3373
fax: 631-444-8848


INVESTOR CONTACT:
Debbie Bailey
631-444-8090
fax: 631-444-8848


FCMN Contact:
Email Contact


PROGRAM CONTACT:
Janice Meraglia
631-444-6293
Web site: http://www.adnas.com
Twitter: @APDN, @APDNInvestor



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES